Adapting FAMS to Optimize CGM Use Among Emerging Adults With Type 1 Diabetes
Launched by VANDERBILT UNIVERSITY MEDICAL CENTER · May 9, 2023
Trial Information
Current as of August 22, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
FAMS (Family/friend Activation to Motivate Self-care) is a mobile phone-delivered intervention, based on Family Systems Theory, which helps adults with diabetes set behavioral goals and improve support received from friends and family for goal success. FAMS includes monthly phone coaching and text message support by FAMS coaches for the person with diabetes (PWD) and the option to enroll a support person (SP) to receive automated texts tailored to the self-care goals the person with T1D sets in coaching sessions. Adaptations specific to CGM include the option to set CGM use goals in coachin...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • PERSONS WITH DIABETES
- • Ages 18-24
- • Have a diagnosis of T1D and has been taking insulin for at least one year
- • Comfortable sending and receiving texts
- • Can speak, read, and write in English
- • Meets one of the following two criteria: 1) has a most recent A1c value in the EHR that is 7.5% or higher (or missing) OR 2) screen positive for diabetes distress on the two-item Diabetes Distress Screen (DDS-2)
- • Using a continuous glucose monitor (CGM)
- • SUPPORT PERSONS
- • Age 18 or older
- • Can speak, read, and write in English or Spanish
- • Comfortable sending and receiving texts
- Exclusion Criteria:
- • PERSONS WITH DIABETES
- • Has a condition that would prohibit study completion (intellectual disability, blindness or auditory limitations, severe mental illness)
- • Plans to live outside the country during the study period
- • SUPPORT PERSONS
- • Shares a phone with the person with diabetes
- • Plans to live outside of the country during the study period
About Vanderbilt University Medical Center
Vanderbilt University Medical Center (VUMC) is a leading academic medical center located in Nashville, Tennessee, renowned for its commitment to advancing healthcare through innovative research and clinical excellence. As a prominent sponsor of clinical trials, VUMC integrates cutting-edge scientific inquiry with patient-centered care, supporting a diverse array of studies aimed at enhancing medical knowledge and improving treatment outcomes. With a robust infrastructure and a multidisciplinary team of experts, VUMC fosters collaboration across various fields, ensuring the highest standards of safety and ethical considerations in its research endeavors. Through its dedication to medical discovery and education, VUMC plays a pivotal role in shaping the future of medicine.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Los Angeles, California, United States
Salt Lake City, Utah, United States
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported